✦ LIBER ✦

Therapy of CLL with humanized CD52 antibody (CAMPATH-1H)

✍ Scribed by Håkan Mellstedt; Jeanette Lundin; Herman Waldman; Geoff Hale; Anders Österborg

Book ID: 117657777
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 103 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80406-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Campath-1H (anti-CD52) monoclonal antibo

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders

✍ G. A. Pangalis; M. N. Dimopoulou; M. K. Angelopoulou; Ch. Tsekouras; T. P. Vassi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 87 KB

298 - Antibody therapy of lympold malign

298 - Antibody therapy of lympold malignancies: Experience with CD52 (CAMPATH-1) antibodies

✍ M.J.S. Dyer 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Recognition of CD52 allelic gene product

Recognition of CD52 allelic gene products by CAMPATH-1H antibodies

✍ C. HALE; M. BARTHOLOMEW; V. TAYLOR; J. STABLES; P. TOPLEY; Dr J. TITE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

134: A Randomized Study Using Humanized

134: A Randomized Study Using Humanized Monoclonal Antibody Against Cd52 (Campath-1h) and Tacrolimus in Heart Transplant Recipients

✍ S.M. Pham; B.M. Bednar; A. Panos; E.J. Bauerlein; F. Jimenez; E. Rosenkrantz; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Synovial tissue responses following trea

Synovial tissue responses following treatment of rheumatoid arthritis with the humanized monoclonal antibody CAMPATH-1H

✍ Enrique R. Soriano; Jonathan Dixey; Nicolas D. Hall; Joan Davies; Peter J. Maddi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Treatment of active refractory rheumatoi

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath-1h administered by daily subcutaneous injection

✍ Eric L. Matteson; David E. Yocum; E. William St. Clair; Antonio A. Achkar; Micha 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Objective. To investigate the dose tolerance and potential clinical activity of a humanized antilymphocyte monoclonal antibody, CAMPATH-1H (ClH), in patients with active, refractory rheumatoid arthritis (RA). Methods. Thirty adult patients with active, refractory RA were treated in an open-label, 3